International Laboratories and Quality Packaging Specialists International are the defendants in a proposed class action focused on an alleged prescription medication bottling error.
The plaintiff states in the 11-page complaint that she was prescribed generic Plavix (Clopidogrel) in 2010 to address her risk of cardiovascular conditions. On January 10, 2018, the lawsuit says, the FDA announced a recall initiated by International Laboratories that affected 218,772 bottles of mislabeled Clopidogrel. A short time later, the case continues, a letter sent to the plaintiff from the Walmart Pharmacy she frequented that said an error was made when bottles of Clopidogrel were mistakenly filled with generic Zocor and/or FloLipid (Simvastatin), an anti-cholesterol medication.
According to the suit, the plaintiff attempted to get a refund from International Laboratories by calling the phone number included in the recall notice but was denied because she had “already consumed the product” and disposed of the mislabeled pill bottle.